Venus Concept INC Schedule 13D activist filings
Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.
EW Healthcare Partners and its affiliates have filed an Amendment No. 18 to Schedule 13D, reporting that they no longer beneficially own any shares of Venus Concept, Inc. common stock.
Madryn Asset Management completed a short-form merger, acquiring all outstanding common stock of Venus Concept Inc. for $0.04 per share, taking the company private.
EW Healthcare Partners has sold a significant portion of its holdings in Venus Concept, Inc. to Madryn Asset Management for $2.6 million.
EW Healthcare Partners and affiliates have agreed to sell their preferred stock and convertible debt holdings in Venus Concept Inc. to Madryn Asset Management for $2.6 million.
Madryn Asset Management proposes a comprehensive debt-for-equity restructuring and short-form merger for Venus Concept Inc., valuing common stock at $0.01 per share.
Madryn Asset Management, a major shareholder, proposes a debt-for-equity swap and new financing for Venus Concept, potentially leading to majority ownership and discussing delisting.
Madryn Asset Management and its affiliates significantly increased their reported beneficial ownership in Venus Concept Inc. to 91.0% following Nasdaq's clarification on preferred stock convertibility.
Madryn Asset Management and its affiliates have increased their beneficial ownership in Venus Concept Inc. to 85.4% of common stock through a series of debt-to-equity exchanges, including a recent swap of convertible notes for Series Y Preferred Stock.
Madryn Asset Management and its affiliated funds have significantly increased their beneficial ownership in Venus Concept Inc. to 85.5% through a series of debt-to-equity exchanges, including a recent conversion of $11.1 million in convertible notes and acquisition of Series Y Preferred Stock.
SCHEDULE 13D/A: Venus Concept Shareholders Approve Key Equity Conversions, Paving Way for Major Investor Madryn to Increase Stake
Venus Concept Inc. shareholders have approved the conversion of Series X and Y Preferred Stock and 2025 Convertible Notes into common stock, removing Nasdaq limitations and significantly increasing Madryn Asset Management's beneficial ownership to 85.5%.
SCHEDULE 13D/A: Madryn Asset Management Boosts Venus Concept Stake Amidst Debt Restructuring Efforts
Madryn Asset Management, a significant lender and investor, has increased its beneficial ownership in Venus Concept Inc. to 8.6% and is actively pursuing a comprehensive debt and equity capital structure restructuring.
SCHEDULE 13D/A: EW Healthcare Partners Amends Venus Concept 13D Filing, Citing Dilution from Recent Offering
EW Healthcare Partners has filed an Amendment No. 15 to its Schedule 13D for Venus Concept, Inc., reporting a decrease in its beneficial ownership percentage due to an increase in the Issuer's outstanding common stock from a recent registered offering.
SCHEDULE 13D/A: EW Healthcare Partners Reports Dilution in Venus Concept Stake Following New Equity Offerings
EW Healthcare Partners and its affiliates have reported a decrease of over 1% in their beneficial ownership of Venus Concept, Inc. common stock, primarily due to the Issuer's recent registered equity offerings.
SCHEDULE 13D/A: Venus Concept Inc. Completes 1-for-11 Reverse Stock Split; Major Shareholder's Stake Adjusted
Venus Concept Inc. has completed a 1-for-11 reverse stock split, leading to an adjustment in the percentage beneficial ownership of its major shareholder, EW Healthcare Partners, due to an increase in outstanding shares.
SCHEDULE 13D/A: Madryn Asset Management Boosts Stake in Venus Concept Amidst Debt Restructuring and Reverse Stock Split
Madryn Asset Management, a significant lender and investor, has increased its beneficial ownership in Venus Concept Inc. to 20% following a series of debt-to-equity exchanges and a recent 11:1 reverse stock split.
SCHEDULE 13D/A: HealthQuest Entities and Garheng Kong Update Significant Stake in Venus Concept Inc. to Nearly 10%
HealthQuest Partners II, L.P., HealthQuest Venture Management II, L.L.C., and Garheng Kong have filed an Amendment No. 5 to their Schedule 13D, updating their beneficial ownership in Venus Concept Inc. to 9.8% and 9.9% respectively, as of December 31, 2024.